Author:
Prueksaritanont Thomayant,Vega José M.,Zhao Jamie,Gagliano Kathleen,Kuznetsova Olga,Musser Bret,Amin Raju D.,Liu Lida,Roadcap Brad A.,Dilzer Stacy,Lasseter K. C.,Rogers J. Douglas
Subject
Pharmacology (medical),Pharmacology
Reference32 articles.
1. Mevinolin: a highly potent competitive inhibitor of hydroxy-methylglutaryl-coenzyme A reductase and a cholesterol-lowering agent;Alberts;Proc Natl Acad Sci,1980
2. In vitro and in vivo biotransformation of simvastatin, an inhibitor of HMG CoA reductase;Vickers;DrugMetab Dispos,1990
3. Metabolic disposition of simvastatin in patients with T-tube drainage;Cheng;DrugMetab Dispos,1994
4. In vitro metabolism of simvastatin in humans: identification of metabolizing enzymes and effect of the drug on hepatic P450s;Prueksaritanont;Drug Metab Dispos,1997
5. Metabolic interactions between mibefradil and HMG-CoA reductase inhibitors: an in vitro investigation with human liver preparations;Prueksaritanont;Br J Clin Pharmacol,1999
Cited by
49 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献